RANDOMIZED TRIAL OF HYPERTHERMIA AS ADJUVANT TO RADIOTHERAPY FOR RECURRENT OR METASTATIC MALIGNANT-MELANOMA

被引:471
作者
OVERGAARD, J
GONZALEZ, DG
HULSHOF, MCCM
ARCANGELI, G
DAHL, O
MELLA, O
BENTZEN, SM
机构
[1] AARHUS UNIV HOSP,DEPT ONCOL,DK-8000 AARHUS,DENMARK
[2] ACAD MED CTR,DEPT RADIOTHERAPY,AMSTERDAM,NETHERLANDS
[3] G PORFIRI ONCOL CTR,DEPT RADIOTHERAPY,LATINA,ITALY
[4] HAUKELAND HOSP,DEPT ONCOL,N-5021 BERGEN,NORWAY
来源
LANCET | 1995年 / 345卷 / 8949期
关键词
D O I
10.1016/S0140-6736(95)90463-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The value of hyperthermia as an adjuvant to radiotherapy in patients with malignant melanoma was studied in European multicentre trial. 134 metastatic or recurrent lesions of malignant melanoma in 70 patients were randomly assigned to receive radiotherapy (three fractions of 8 Gy or 9 Gy in 8 days) alone or followed by hyperthermia (43 degrees C for 60 min). Overall, the 2-year actuarial local tumour control was 37(SE 5)%. Univariate analysis showed a beneficial effect of hyperthermia (radiation alone 28% vs combined treatment 46%, p=0.008) and radiation dose (24 Gy 25% vs 27 Gy 56%, p=0.02), but no effect of tumour size (less than or equal to 4 cm 42% vs >4 cm 29%, p=021). Cox multivariate regression analysis showed the most important prognostic variables to be hyperthermia (odds ratio for 2-year local control 1.73 [95% CI 1.07-2.78], p=0.023), tumour size (0.91 [0.85-0.99], p=0.05), and radiation dose (1.17 [1.01-1.36], p=0.05). Addition of heat did not significantly increase acute or late radiation reactions. Heating was well tolerated, but because of difficulties with equipment only 14% of treatments achieved the protocol objective. The overall 5-year survival rate was 19%, but 38% of the patients for whom all known disease was controlled survived 5 years. Adjuvant hyperthermia significantly improved local tumour control when applied in association with radiation in treatment of malignant melanoma. Successful local treatment of patients with a single or a few metastatic malignant melanoma lesions has significant curative potential.
引用
收藏
页码:540 / 543
页数:4
相关论文
共 28 条
[1]   CLINICAL RADIOBIOLOGY OF MALIGNANT-MELANOMA [J].
BENTZEN, SM ;
OVERGAARD, J ;
THAMES, HD ;
OVERGAARD, M ;
HANSEN, PV ;
VONDERMAASE, H ;
MEDER, J .
RADIOTHERAPY AND ONCOLOGY, 1989, 16 (03) :169-182
[2]   PERSISTENT AND OR LATE COMPLICATIONS OF COMBINED RADIATION-THERAPY AND HYPERTHERMIA [J].
BENYOSEF, R ;
KAPP, DS .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1992, 8 (06) :733-745
[3]  
BERDEAUX DH, 1985, CANCER TREAT REP, V69, P397
[4]  
BLOIS MS, 1983, CANCER-AM CANCER SOC, V52, P1330, DOI 10.1002/1097-0142(19831001)52:7<1330::AID-CNCR2820520732>3.0.CO
[5]  
2-M
[6]   CORRELATION OF THERMAL PARAMETERS WITH OUTCOME IN COMBINED RADIATION THERAPY-HYPERTHERMIA TRIALS [J].
COX, RS ;
KAPP, DS .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1992, 8 (06) :719-732
[7]   INTERSOCIETY COUNCIL ON RADIATION ONCOLOGY ESSAY ON THE INTRODUCTION OF NEW MEDICAL TREATMENTS INTO PRACTICE [J].
DEWHIRST, MW ;
GRIFFIN, TW ;
SMITH, AR ;
PARKER, RG ;
HANKS, GE ;
BRADY, LW .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (12) :951-957
[8]  
ENGIN K, 1992, INT J RADIAT ONCOL, V25, P87
[9]   COMBINED TREATMENT WITH RADIATION AND HYPERTHERMIA IN METASTATIC MALIGNANT-MELANOMA [J].
GONZALEZ, DG ;
VANDIJK, JDP ;
BLANK, LECM ;
RUMKE, P .
RADIOTHERAPY AND ONCOLOGY, 1986, 6 (02) :105-113
[10]   QUALITY ASSURANCE GUIDELINES FOR ESHO PROTOCOLS [J].
HAND, JW ;
LAGENDIJK, JJW ;
ANDERSEN, JB ;
BOLOMEY, JC .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1989, 5 (04) :421-428